Endocrinology in 2012: What's new?;Endocrinologie, quoi de neuf en 2012?

Revue Medicale Suisse

Volumn 9, Issue 368, 2013, Pages 36-39

  Parrat, D ^a   Meyer, P ^b  

^a SERVICE DE MÉDECINE INTERNE GÉNÉRALE   (Switzerland)

^b HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ARTICLE; BENIGN TUMOR; CARDIOVASCULAR MORTALITY; CYTODIAGNOSIS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INTELLECTUAL IMPAIRMENT; MARKER GENE; MATERNAL HYPOTHYROIDISM; MORBIDITY; PREGNANCY; SUBCLINICAL HYPOTHYROIDISM; THYROID GLAND EXAMINATION; THYROID NODULE;

CARDIOVASCULAR DISEASES; CONGENITAL HYPOTHYROIDISM; ENDOCRINOLOGY; FEMALE; HUMANS; HYPOTHYROIDISM; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; RISK FACTORS; THYROID NODULE;

EID: 84872735593     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. * Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55.
2. Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: A 3-years follow-up study. Clin Endocrinol (Oxf) 2003;59:282-8.
3. Henrichs J, Bongers-Schokking JJ, Schenk JJ, et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: The generation R study. J Clin Endocrinol Metab 2010;95:4227-34.
4. Craig W, Allan CA, Kloza EM, et al. Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J Clin Endocrinol Metab 2012;97:E22-8.
5. ** Lazarus JH, Bestwick JP, Channon MScS, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012;366:493-501.
6. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Thyroid therapy for mild thyroid deficiency in pregnany (TSH). Bethesda, MD: National Library of Medicine (www.clinicaltrials.gov/ct/ show/NCT00388297).
7. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-91.
8. Negro R, Schwartz A, Gismondi R, et al. Universal screening versus cae finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010;95:1699-707.
9. * Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012;172:799-809.
10. ** Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: An individual participant data analysis from six prospetive cohorts. Circulation AHA 2012, http://circ.ahajournals.org/content/early/2012/07/17/CIRCULATIONAHA.112.096024
11. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002;360:1623-30.
12. Nanchen D, Gussekloo J, Westendorp RGJ, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012;97:852-61.
13. Ferraz C, Ezlinger M, Paschke R. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 2011;96:2016-26.
14. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodule: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:3390-7.
15. Xing M, Clark D, Guan H, et al. BRAF Mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009;27:2977-82.
16. Nikiforova MN, Tseng GC, Steward D, et al. MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J Clin Endocrinol Metab 2008:93:1600-8.
17. Pallante P, Visone R, Ferracin M, et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 2006;13:497-508.
18. de la Chapelle A, Jazdzewski K. MicroRNAs in thyroid cancer. J Clin Endocrinol Metab 2011;96:3326-36.
19. ** Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 2010;95:5296-304.
20. ** Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of begnin thyroid nodules with indeterminate cytology. N Engl J Med 2012;367:705-15.